Detalles de la búsqueda
1.
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.
Gynecol Oncol
; 170: 300-308, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36758420
2.
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.
Cancer
; 125(14): 2445-2454, 2019 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31034598
3.
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
Invest New Drugs
; 36(1): 103-113, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29127533
4.
Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer.
Gynecol Oncol
; 140(2): 210-4, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26644263
5.
Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer.
Gynecol Oncol
; 129(3): 452-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23474348
6.
Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk.
Hum Mol Genet
; 17(9): 1336-48, 2008 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18204050
7.
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer.
Clin Cancer Res
; 24(2): 316-325, 2018 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29084918
8.
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse.
J Clin Oncol
; 34(19): 2271-8, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27001568
9.
A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors.
Clin Cancer Res
; 21(6): 1281-8, 2015 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25398449
10.
Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.
Lung Cancer
; 68(3): 455-9, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19744744
11.
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study.
Clin Cancer Res
; 16(21): 5288-95, 2010 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20855460
Resultados
1 -
11
de 11
1
Próxima >
>>